Inhibition of HDAC activation or neutralization of IL-6 in colorectal cancer tissues can down-regulate the expression of immunosuppressant and chemotaxis-related genes in myeloid cells, confirming the importance of HDAC activation and IL-6 signaling pathways in the function and chemotaxis of MDSCs [84]. The gene discussed is HDAC9; the disease is colorectal cancer.